학술논문
Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
Document Type
Article
Author
Source
In: Journal of the American Academy of Dermatology . (Journal of the American Academy of Dermatology, August 2022, 87(2):351-358)
Subject
Language
English
ISSN
10976787
01909622
01909622